Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
American College of Cardiology 71st Scientific Sessions: Science Preview, April 2, 2022
ACC 2022. ACC late-breaking clinical trial sessions begin Sat, April 2, 2022. Our short slide shows highlight the studies of interest to primary care clinicians.
At the American College of Cardiology's 71st Scientific Session in Washington, DC, April 2-4, the latest findings spanning the breadth of cardiovascular disease research will be presented in late-breaking science sessions on all 3 days.
Whether you are attending in person or remotely, use these quick slide-show guides to review sessions and study titles. Use the "late-breaking" link to visit the ACC program page where all study abstracts will be available as the findings are presented. Start below with the hot topics on Day 1, including research on mavacamten, sotagliflozin, and bentracimab.
Sunday, April 3, 2022 Late Breaking Clincial Trials
Monday, April 4, 2022 Late Breaking Clinical Trials
More News from ACC on Patient Care
Related Videos
Related Content
